Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Helen Kovari
  • Caroline A Sabin
  • Bruno Ledergerber
  • Ryom, Lene
  • Signe W Worm
  • Colette Smith
  • Andrew Phillips
  • Peter Reiss
  • Eric Fontas
  • Kathy Petoumenos
  • Stéphane De Wit
  • Philippe Morlat
  • Lundgren, Jens
  • Rainer Weber
Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality.
OriginalsprogEngelsk
TidsskriftClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Vol/bind56
Udgave nummer6
Sider (fra-til)870-9
Antal sider10
DOI
StatusUdgivet - mar. 2013

ID: 105603520